<span item_type="fundamental" item_id="4c1a711c3f5d3986b2f7bfec61302361" counter_id="ST/US/OXBRW" env="prod"></span><span item_type="announcement" item_id="579897331655773186" env="prod"></span><p>Revenue: As of FY2025 Q3, the actual value is USD 645 K.</p><p>EPS: As of FY2025 Q3, the actual value is USD -0.02.</p><p>EBIT: As of FY2025 Q3, the actual value is USD -170 K.</p><p></p><h3>Segment Revenue</h3><ul><li>Net premiums earned for the quarter ended September 30, 2025 decreased to $555,000 from $595,000 for the quarter ended September 30, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1584831/000149315225021064/ex99-1.htm"></span></li><li>Net premiums earned for the nine-months ended September 30, 2025 increased to $1.73 million from $1.71 million for the nine-month period ended September 30, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1584831/000149315225021064/ex99-1.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li>Net loss for the quarter ended September 30, 2025 was $187,000, or - $0.02 basic and diluted loss per share compared to a net loss of $540,000, or - $0.09 basic and diluted loss per share, for the quarter ended September 30, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1584831/000149315225021064/ex99-1.htm"></span></li><li>Net loss for the nine-months ending September 30, 2025 was $2.19 million, or - $0.30 basic and diluted loss per share compared to a net loss of $2.27 million, or - $0.37 basic and diluted loss per share, for the nine months ending September 30, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1584831/000149315225021064/ex99-1.htm"></span></li><li>Total expenses for the three months ended September 30, 2025 increased to $815,000 from $498,000 for the quarter ended September 30, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1584831/000149315225021064/ex99-1.htm"></span></li><li>Total expenses for the nine months ending September 30, 2025 increased to $4.99 million from $1.67 million for the nine months ending September 30, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1584831/000149315225021064/ex99-1.htm"></span></li></ul><h3>Cash Flow</h3><ul><li>As of September 30, 2025, restricted cash and cash equivalents increased by $1.28 million or 21.7%, to $7.18 million, from $5.9 million as of December 31, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1584831/000149315225021064/ex99-1.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li>The Balanced Yield Token (EtaCat Re) is tracking approximately 25% annual return, exceeding its 20% target, while the High Yield Token (ZetaCat Re) remains on track to meet its 42% target.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1584831/000149315225021064/ex99-1.htm"></span></li></ul><h3>Outlook / Guidance</h3><ul><li>Oxbridge Re Holdings Limited is considering introducing regular dividend payouts on its security-backed CatRe tokens, moving away from a purely annual payout model.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1584831/000149315225021064/ex99-1.htm"></span></li></ul>

Oxbridge Re Holdings - CW24 | 8-K: FY2025 Q3 Revenue: USD 645 K